Publications by authors named "Chad Tang"

Claim this Profile
C
Current and Upcoming Trials in Localized Prostate Cancer.
Landan P MacDonald, Andrew M Fang, Chad Tang, Brian F Chapin

Urol Clin North Am· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to: Revisiting Radium-223 in Oligometastatic Castration-Sensitive Prostate Cancer: RAVENS Trial Insights.
Phuoc T Tran, Jarey H Wang, Chad Tang, Ana P Kiess

J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers.
Rana R McKay, Sumanta Pal, Wanling Xie, David Aggen, Laurence Albiges, Chad Tang

CA Cancer J Clin· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous Androgen Deprivation Therapy with or Without Metastasis-directed Therapy for Oligometastatic Prostate Cancer: The Multicenter Phase 2 Randomized EXTEND Trial.
Alexander D Sherry, Bilal A Siddiqui, Cara Haymaker, Bryan M Fellman, Marina N Medina-Rosales, Chad Tang

Eur Urol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing biomarkers and methods of risk stratification: Consensus statements from the International Kidney Cancer Symposium North America 2024 Think Tank.
Daniel D Shapiro, Edwin Jason Abel, Laurence Albiges, Dena Battle, Stephanie A Berg, Chad Tang

Urol Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of brachytherapy-induced prostate edema on postimplant dosimetric analysis in patients treated with magnetic resonance imaging-assisted radiosurgery (MARS).
Kathryn E Marqueen, Kelsey L Corrigan, Surendra Prajapati, Rajat J Kudchadker, Gohar Manzar, Chad Tang

Brachytherapy· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastasis-directed radiotherapy without systemic therapy for oligometastatic clear-cell renal-cell carcinoma: primary efficacy analysis of a single-arm, single-centre, phase 2 trial.
Chad Tang, Alexander D Sherry, Aaron Seo, Kieko Hara, Haesun Choi

Lancet Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular disease and diagnosis of advanced prostate cancer.
Kevin T Nead, Allen M Haas, Jing Zhao, Ting Xiong, Chad Tang

Cardiooncology· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating systemic therapy and metastasis-directed therapy in oligometastatic hormone-sensitive prostate cancer.
Xiaolei Shi, Jarey H Wang, Brian F Chapin, Ana Aparicio, Sumit K Subudhi, Chad Tang

Prostate Cancer Prostatic Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Report: Successful delivery following chemotherapy in a pregnant patient with metastatic SMARCB1-deficient renal medullary carcinoma.
Panayiotis D Kontoyiannis, Adam Kuykendal, Chad Tang, Jessica P Cheng, Beei Chan

Front Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic Body Radiation Therapy Alone or in Combination with Immunotherapy in Kidney Cancer: A Systematic Review.
Nora Sundahl, Laurence Albiges, Toni K Choueiri, Elise De Bleser, Gert De Meerleer, Chad Tang

Eur Urol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of Longitudinal Relaxation Rate Mapping with Non-Cartesian Sampling and Compressed Sensing on a 1.5T MR-Linac.
Lucas McCullum, Michael J van Rijssel, Ken-Pin Hwang, Yao Ding, Chad Tang

medRxiv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Radium-223 and Stereotactic Ablative Radiotherapy Versus Stereotactic Ablative Radiotherapy for Oligometastatic Prostate Cancers: The RAVENS Phase II Randomized Trial.
Jarey H Wang, Alexander D Sherry, Soha Bazyar, Philip Sutera, Noura Radwan, Chad Tang

J Clin Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypofractionated, Dose-Escalated Radiation Versus Conventionally Fractionated Radiation for Localized Prostate Cancer: Long-Term Update of a Phase III, Prospective, Randomized Controlled Trial.
Comron Hassanzadeh, Deborah Kuban, Sarah Pasyar, Roland Bassett, Patricia Troncoso, Chad Tang

J Clin Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PACE-B: Where does this position SBRT as an option for localized prostate cancer?
Juanita Crook, Pierre Blanchard, Jay Ciezki, Gregory Merrick, Jeremy Millar, Chad Tang

Radiother Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and early outcomes of proton therapy and low-dose rate brachytherapy boost for patients with prostate cancer.
Osama Mohamad, Zakaria El Kouzi, Ramez Kouzy, Seungtaek Choi, Henry Mok, Chad Tang

Brachytherapy· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical Considerations for the Treatment of Primary Renal Cell Carcinoma With SABR.
James B Yu, David Grew, Erin Sculley, Shankar Siva, Nicholas Hardcastle, Chad Tang

Pract Radiat Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early outcomes following local salvage treatment with MRI-assisted low-dose rate brachytherapy (MARS) for MRI-visible postsurgical bed recurrences and focal intraprostatic recurrences.
Comron Hassanzadeh, Osama Mohamad, Teresa Bruno, Lin Wang, Rajat Kudchakar, Chad Tang

Brachytherapy· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adding Metastasis-Directed Therapy to Standard-of-Care Systemic Therapy for Oligometastatic Breast Cancer (EXTEND): A Multicenter, Randomized Phase 2 Trial.
Jay P Reddy, Alexander D Sherry, Bryan Fellman, Suyu Liu, Tharakeswara Bathala, Chad Tang

Int J Radiat Oncol Biol Phys· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostatectomy and other local treatments for oligometastatic prostate cancer: recent and ongoing trials.
Andrew M Fang, Landan P MacDonald, Justin R Gregg, Bilal A Siddiqui, Chad Tang

Curr Opin Urol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADT with SBRT versus SBRT alone for hormone-sensitive oligorecurrent prostate cancer (RADIOSA): a randomised, open-label, phase 2 clinical trial.
Giulia Marvaso, Giulia Corrao, Mattia Zaffaroni, Maria Giulia Vincini, Chiara Lorubbio, Chad Tang

Lancet Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolving Paradigms in the Treatment of Oligometastatic Pancreatic Ductal Adenocarcinoma.
Enoch Chang, Alexander D Sherry, Jakob Liermann, Amir Abdollahi, Ching-Wei D Tzeng, Chad Tang

J Gastrointest Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current State of Stereotactic Body Radiation Therapy for Genitourinary Malignancies.
Alexander D Sherry, Neil Desai, Chad Tang

Cancer J· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upper Urinary Tract Stereotactic Body Radiotherapy Using a 1.5 Tesla Magnetic Resonance Imaging-Guided Linear Accelerator: Workflow and Physics Considerations.
Yao Zhao, Adrian Cozma, Yao Ding, Luis Augusto Perles, Reza Reiazi, Chad Tang

Cancers (Basel)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical study and parallel phase II trial evaluating antisense STAT3 oligonucleotide and checkpoint blockade for advanced pancreatic, non-small cell lung cancer and mismatch repair-deficient colorectal cancer.
Chad Tang, Genevieve P Hartley, Coline Couillault, Ying Yuan, Heather Lin

BMJ Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis